POM-V Prescription Required

Meloxidolor 20 mg/ml Solution for Injection for Cattle, Pigs and Horses

Active ingredient: Meloxicam

Form

Injection

Species

Cattle Horses Pigs

Manufacturer

Le Vet Beheer B.V.

VMD MA No.

41821/5004

What it's used for

For use in diarrhoea in combination with oral re-hydration therapy to reduce clinical signs in calves of over one week of age and young, non-lactating catt...

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Meloxicam

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Meloxidolor 20 mg/ml Solution for Injection for Cattle, Pigs and Horses — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

For use in diarrhoea in combination with oral re-hydration therapy to reduce clinical
signs in calves of over one week of age and young, non-lactating cattle.
For adjunctive therapy in the treatment of acute mastitis, in combination with
antibiotic therapy.
For the relief of post-operative pain following dehorning in calves.
Pigs:
For use in non-infectious locomotor disorders to reduce the symptoms of lameness
and inflammation.
For adjunctive therapy in the treatment of puerperal septicaemia and toxaemia
(mastitis-metritis-agalactia syndrome) with appropriate antibiotic therapy.
Horses:
For use in the alleviation of inflammation and relief of pain in both acute and chronic
musculo-skeletal disorders.
For the relief of pain associated with equine colic.

body weight (i.e. 2.5 ml/100 kg body weight) in combination with antibiotic therapy or
with oral re-hydration therapy, as appropriate.
Pigs:
Single intramuscular injection at a dosage of 0.4 mg meloxicam/kg body weight (i.e.
2 m l/100 kg body weight) in combination with antibiotic therapy, as appropriate. If
required, a second administration of meloxicam can be given after 24 hours.
Horses:
Single intravenous injection at a dosage of 0.6 mg meloxicam/kg body weight (i.e.
3 ml/100 kg body weight).
Avoid introduction of contamination during use. The stopper should not be punctured
more than 20 times.

Do not use in cases of hypersensitivity to the active substance or to any of the
excipients.
Do not use in horses less than 6 weeks of age.
Do not use in animals suffering from impaired hepatic, cardiac or renal function and
haemorrhagic disorders, or where there is evidence of ulcerogenic gastrointestinal
lesions.
For the treatment of diarrhoea in cattle, do not use in animals of less than one week
of age
See also section 3.7.

Cattle:
Very rare
(<1 animal / 10,000 animals
treated, including isolated
reports):
Injection site swelling
a
Anaphylactic reaction
b
a
Following subcutaneous injection: slight and transient.
b
May be serious (including fatal) and should be treated symptomatically.
Pig:
Very rare
(<1 animal / 10,000 animals
treated, including isolated
reports):
Anaphylactic reaction
a
a
May be serious (including fatal) and should be treated symptomatically.
Horse:
Rare
(1 to 10 animals / 10,000
animals treated):
Injection site swelling
a
Very rare
(<1 animal / 10,000 animals
treated, including isolated
reports):
Anaphylactic reaction
b
a
Transient and resolves without intervention.
b
May be serious (including fatal) and should be treated symptomatically.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian,
to either the marketing authorisation holder or its local representative or the national
competent authority via the national reporting system. See the package leaflet for
respective contact details.

Treatment of calves with Meloxidolor 20 minutes before dehorning reduces post-
operative pain. Meloxidolor alone will not provide adequate pain relief during the
dehorning procedure. To obtain adequate pain relief during surgery co-medication
with an appropriate analgesic is needed.

Special precautions for safe use in the target species:
If adverse reactions occur, treatment should be discontinued and the advice of a
veterinarian should be sought.
Avoid use in very severely dehydrated, hypovolaemic or hypotensive animals which
require parenteral rehydration, as there may be a potential risk of renal toxicity.
In case of inadequate relief of pain when used in the treatment of equine colic,
careful re-evaluation of the diagnosis should be made as this could indicate the need
for surgical intervention.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
Accidental self-injection may give rise to pain. People with known hypersensitivity to
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) should avoid contact with the
veterinary medicinal product.
In case of accidental self-injection, seek medical advice immediately and show the
package leaflet or the label to the physician.
The veterinary medicinal product should not be administered by pregnant women or
women of child-bearing potential as Meloxicam may be harmful to the foetus and
unborn child.
Special precautions for the protection of the environment:
Not applicable.

Do not administer concurrently with glucocorticosteroids, other non-steroidal anti-
inflammatory drugs or with anticoagulant agents.

This veterinary medicinal product does not require any special storage conditions.

Cattle:
Milk: 5 days
Pigs:
Horses:
Not authorised for use in horses producing milk for human consumption.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.